Your browser doesn't support javascript.
loading
Sophisticated natural products as antibiotics.
Lewis, Kim; Lee, Richard E; Brötz-Oesterhelt, Heike; Hiller, Sebastian; Rodnina, Marina V; Schneider, Tanja; Weingarth, Markus; Wohlgemuth, Ingo.
Afiliação
  • Lewis K; Antimicrobial Discovery Center, Northeastern University, Boston, MA, USA. k.lewis@northeastern.edu.
  • Lee RE; Department of Chemical Biology and Therapeutics, St Jude Children's Research Hospital, Memphis, TN, USA. richard.lee@stjude.org.
  • Brötz-Oesterhelt H; Interfaculty Institute of Microbiology and Infection Medicine, Tubingen, Germany.
  • Hiller S; Controlling Microbes to Fight Infection-Cluster of Excellence, Tubingen, Germany.
  • Rodnina MV; Biozentrum, University of Basel, Basel, Switzerland.
  • Schneider T; Max Planck Institute for Multidisciplinary Sciences, Goettingen, Germany.
  • Weingarth M; Institute for Pharmaceutical Microbiology, University of Bonn, University Hospital Bonn, Bonn, Germany.
  • Wohlgemuth I; German Center for Infection Research (DZIF), Partner Site Cologne-Bonn, Bonn, Germany.
Nature ; 632(8023): 39-49, 2024 Aug.
Article em En | MEDLINE | ID: mdl-39085542
ABSTRACT
In this Review, we explore natural product antibiotics that do more than simply inhibit an active site of an essential enzyme. We review these compounds to provide inspiration for the design of much-needed new antibacterial agents, and examine the complex mechanisms that have evolved to effectively target bacteria, including covalent binders, inhibitors of resistance, compounds that utilize self-promoted entry, those that evade resistance, prodrugs, target corrupters, inhibitors of 'undruggable' targets, compounds that form supramolecular complexes, and selective membrane-acting agents. These are exemplified by ß-lactams that bind covalently to inhibit transpeptidases and ß-lactamases, siderophore chimeras that hijack import mechanisms to smuggle antibiotics into the cell, compounds that are activated by bacterial enzymes to produce reactive molecules, and antibiotics such as aminoglycosides that corrupt, rather than merely inhibit, their targets. Some of these mechanisms are highly sophisticated, such as the preformed ß-strands of darobactins that target the undruggable ß-barrel chaperone BamA, or teixobactin, which binds to a precursor of peptidoglycan and then forms a supramolecular structure that damages the membrane, impeding the emergence of resistance. Many of the compounds exhibit more than one notable feature, such as resistance evasion and target corruption. Understanding the surprising complexity of the best antimicrobial compounds provides a roadmap for developing novel compounds to address the antimicrobial resistance crisis by mining for new natural products and inspiring us to design similarly sophisticated antibiotics.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bactérias / Produtos Biológicos / Antibacterianos Limite: Animals / Humans Idioma: En Revista: Nature Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bactérias / Produtos Biológicos / Antibacterianos Limite: Animals / Humans Idioma: En Revista: Nature Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos